HPGC Renmintongtai Pharmaceutical Corp (600829.SS)
27 May 2019
Latest Key Developments (Source: Significant Developments)
Dec 27 (Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>::SAYS CITIC CAPITAL INVESTMENT FUND PLANS TO INVEST 1.5 BILLION YUAN ($228.87 million) IN CONTROLLING SHAREHOLDER HARBIN PHARMACEUTICAL GROUP.SAYS CITIC CAPITAL HOLDINGS WILL BECOME CO'S OWNER AFTER CITIC CAPITAL HOLDINGS' AFFILIATES OWN 60.86 PERCENT STAKE IN HARBIN PHARMACEUTICAL GROUP AFTER TRANSACTION. Full Article
Nov 29 (Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>::SAYS BOARD ELECTS ZHANG ZHENPING AS CHAIRMAN. Full Article
Aug 11(Reuters) - HPGC Renmintongtai Pharmaceutical Corp <600829.SS>:Says it and Harbin Pharmaceutical Group Co Ltd <<<600664.SS>>> jointly set up a Harbin-based pharmaceutical firm, with registered capital of 50 million yuan .Says the company holds a 99 percent stake in the pharmaceutical firm. Full Article
SHANGHAI, April 24 Chinese stocks rose slightly on Wednesday, recouping early losses, as an afternoon rally in technology shares offset concerns that the central bank could scale back the scope of further policy easing.